D-S Wang1, B Zhong, M-S Zhang, Y Gao. 1. Department of General Surgery, the Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China. beizhong_ahqu@163.com.
Abstract
OBJECTIVE: Circulating microRNAs (miRNAs) have been reported as biomarkers for the early detection of colorectal cancer (CRC). We aimed at evaluating the diagnostic and prognostic value of serum miR-103 in CRC patients. PATIENTS AND METHODS: Quantitative reverse-transcription PCR (qRT-PCR) was applied to measure the miR-103 levels in blood samples of 96 patients and 60 controls. RESULTS: Our results demonstrated that serum miR-103 was overexpressed in CRC subjects and the receiver operating characteristic (ROC) curve analysis showed that serum miR-103 could differentiate CRC cases from controls with relatively high accuracy. In addition, serum miR-103 level was more frequently detected in CRC patients with positive lymph node metastasis, distant metastasis and advanced tumor stage. Moreover, serum miR-103 levels in 23 postoperative blood samples were lower than paired preoperative plasma specimens, and serum miR-103 levels were re-elevated in seven patients at recurrence. Furthermore, serum miR-103 was significantly correlated with worse clinical factors, as well as poorer recurrence-free survival or overall survival. Finally, multivariate analysis confirmed that serum miR-103 was an independent prognostic marker for CRC. CONCLUSIONS: Taken together, serum miR-103 might be a promising biomarker for diagnosis and prognosis of CRC.
OBJECTIVE: Circulating microRNAs (miRNAs) have been reported as biomarkers for the early detection of colorectal cancer (CRC). We aimed at evaluating the diagnostic and prognostic value of serum miR-103 in CRC patients. PATIENTS AND METHODS: Quantitative reverse-transcription PCR (qRT-PCR) was applied to measure the miR-103 levels in blood samples of 96 patients and 60 controls. RESULTS: Our results demonstrated that serum miR-103 was overexpressed in CRC subjects and the receiver operating characteristic (ROC) curve analysis showed that serum miR-103 could differentiate CRC cases from controls with relatively high accuracy. In addition, serum miR-103 level was more frequently detected in CRC patients with positive lymph node metastasis, distant metastasis and advanced tumor stage. Moreover, serum miR-103 levels in 23 postoperative blood samples were lower than paired preoperative plasma specimens, and serum miR-103 levels were re-elevated in seven patients at recurrence. Furthermore, serum miR-103 was significantly correlated with worse clinical factors, as well as poorer recurrence-free survival or overall survival. Finally, multivariate analysis confirmed that serum miR-103 was an independent prognostic marker for CRC. CONCLUSIONS: Taken together, serum miR-103 might be a promising biomarker for diagnosis and prognosis of CRC.
Authors: Mireya Cisneros-Villanueva; Lizbett Hidalgo-Pérez; Alberto Cedro-Tanda; Mónica Peña-Luna; Marco Antonio Mancera-Rodríguez; Eduardo Hurtado-Cordova; Irene Rivera-Salgado; Alejandro Martínez-Aguirre; Silvia Jiménez-Morales; Luis Alberto Alfaro-Ruiz; Rocío Arellano-Llamas; Alberto Tenorio-Torres; Carlos Domínguez-Reyes; Felipe Villegas-Carlos; Magdalena Ríos-Romero; Alfredo Hidalgo-Miranda Journal: Front Oncol Date: 2021-04-12 Impact factor: 6.244